Cervical cancer prevention among long-term screening non-attendees by vaginal self-collected samples for hr-HPV mRNA detection

[1] Arbyn M(2009)Trends of cervical cancer mortality in the member states of the European Union Eur J Cancer 45 2640-2648

[2] Raifu AO(2018)An overview of cervical cancer epidemiology and prevention in Scandinavia Acta Obstet Gynecol Scand 97 795-807

[3] Weiderpass E(2008)Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden J Natl Cancer Inst 100 622-629

[4] Bray F(1999)Human papillomavirus is a necessary cause of invasive cervical cancer worldwide J Pathol 189 12-19

[5] Anttila A(2015)Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening? Clin Microbiol Infect 21 817-826

[6] Pedersen K(2015)Human papillomavirus oncogenic mRNA testing for cervical cancer screening: baseline and longitudinal results from the CLEAR study Am J Clin Pathol 144 473-483

[7] Fogelberg S(2018)Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses BMJ 363 k4823-1420

[8] Thamsborg LH(2018)Home self-collection by mail to test for human papillomavirus and sexually transmitted infections Obstet Gynecol 132 1412-368

[9] Clements M(2014)Evaluation of a new APTIMA specimen collection and transportation kit for high-risk human papillomavirus E6/E7 messenger RNA in cervical and vaginal samples Sex Transm Dis 41 365-73

[10] Nygard M(2018)Self-sampling with HPV mRNA analyses from vagina and urine compared with cervical samples J Clin Virol 101 69-20

[1] Arbyn M(2009)Trends of cervical cancer mortality in the member states of the European Union Eur J Cancer 45 2640-2648

[2] Raifu AO(2018)An overview of cervical cancer epidemiology and prevention in Scandinavia Acta Obstet Gynecol Scand 97 795-807

[3] Weiderpass E(2008)Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden J Natl Cancer Inst 100 622-629

[4] Bray F(1999)Human papillomavirus is a necessary cause of invasive cervical cancer worldwide J Pathol 189 12-19

[5] Anttila A(2015)Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening? Clin Microbiol Infect 21 817-826

[6] Pedersen K(2015)Human papillomavirus oncogenic mRNA testing for cervical cancer screening: baseline and longitudinal results from the CLEAR study Am J Clin Pathol 144 473-483

[7] Fogelberg S(2018)Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses BMJ 363 k4823-1420

[8] Thamsborg LH(2018)Home self-collection by mail to test for human papillomavirus and sexually transmitted infections Obstet Gynecol 132 1412-368

[9] Clements M(2014)Evaluation of a new APTIMA specimen collection and transportation kit for high-risk human papillomavirus E6/E7 messenger RNA in cervical and vaginal samples Sex Transm Dis 41 365-73

[10] Nygard M(2018)Self-sampling with HPV mRNA analyses from vagina and urine compared with cervical samples J Clin Virol 101 69-20